Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Taiwanese (TAIEX) Pharma Industry Analysis

UpdatedMay 27, 2026
DataAggregated Company Financials
Companies59
  • 7D-1.1%
  • 3M-21.8%
  • 1Y-7.2%
  • YTD-19.9%

Over the last 7 days, the Pharma industry has dropped 1.1%, driven by Bora Pharmaceuticals declining 9.6%. Overall the industry is down 7.2% in 12 months. As for the next few years, earnings are expected to grow by 93% per annum.

Industry Valuation and Performance

Has the Taiwanese Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 28 May 2026NT$595.8bNT$123.1bNT$19.0b17.5x31.3x4.8x
Sat, 25 Apr 2026NT$608.7bNT$119.5bNT$20.7b14.5x29.4x5.1x
Mon, 23 Mar 2026NT$623.8bNT$119.3bNT$20.5b14.9x30.5x5.2x
Wed, 18 Feb 2026NT$755.2bNT$119.3bNT$12.3b16.8x61.2x6.3x
Fri, 16 Jan 2026NT$791.3bNT$119.3bNT$12.4b17.3x63.7x6.6x
Sun, 14 Dec 2025NT$756.1bNT$118.0bNT$12.3b16.9x61.5x6.4x
Tue, 11 Nov 2025NT$702.3bNT$118.3bNT$9.4b16.6x74.7x5.9x
Thu, 09 Oct 2025NT$793.0bNT$118.3bNT$9.6b16x82.5x6.7x
Sat, 06 Sep 2025NT$917.9bNT$118.4bNT$10.3b16.7x89.1x7.8x
Mon, 04 Aug 2025NT$660.0bNT$116.7bNT$14.3b18.2x46.2x5.7x
Wed, 02 Jul 2025NT$679.8bNT$116.0bNT$14.3b18.6x47.6x5.9x
Fri, 30 May 2025NT$601.5bNT$115.9bNT$14.3b19.2x42.2x5.2x
Sun, 27 Apr 2025NT$538.5bNT$112.8bNT$10.6b18.2x50.8x4.8x
Tue, 25 Mar 2025NT$648.6bNT$112.8bNT$10.9b19.7x59.7x5.7x
Thu, 20 Feb 2025NT$672.5bNT$109.3bNT$11.5b23.3x58.5x6.2x
Sat, 18 Jan 2025NT$599.8bNT$109.3bNT$11.4b21.1x52.5x5.5x
Mon, 16 Dec 2024NT$583.4bNT$109.3bNT$11.4b21.9x51x5.3x
Wed, 13 Nov 2024NT$630.5bNT$105.5bNT$9.6b24.9x65.7x6x
Fri, 11 Oct 2024NT$627.1bNT$104.7bNT$8.9b27.1x70.1x6x
Sun, 08 Sep 2024NT$630.2bNT$104.7bNT$8.9b25.7x70.5x6x
Tue, 06 Aug 2024NT$594.0bNT$100.5bNT$6.8b26.9x87x5.9x
Thu, 04 Jul 2024NT$713.9bNT$100.5bNT$6.8b32.4x104.6x7.1x
Sat, 01 Jun 2024NT$625.0bNT$100.4bNT$7.1b29.5x87.5x6.2x
Mon, 29 Apr 2024NT$621.0bNT$101.8bNT$9.4b25.4x66.4x6.1x
Wed, 27 Mar 2024NT$630.3bNT$101.1bNT$9.5b26.1x66.7x6.2x
Fri, 23 Feb 2024NT$642.8bNT$101.6bNT$8.2b24.1x78.8x6.3x
Sun, 21 Jan 2024NT$589.0bNT$101.9bNT$7.8b24.2x75.6x5.8x
Tue, 19 Dec 2023NT$587.4bNT$101.6bNT$7.6b24.7x77x5.8x
Thu, 16 Nov 2023NT$559.7bNT$101.6bNT$8.9b21.6x62.6x5.5x
Sat, 14 Oct 2023NT$536.6bNT$101.7bNT$9.6b20.9x55.8x5.3x
Mon, 11 Sep 2023NT$547.8bNT$101.7bNT$9.6b22.4x56.9x5.4x
Wed, 09 Aug 2023NT$569.3bNT$98.5bNT$10.0b16.7x57.2x5.8x
Fri, 07 Jul 2023NT$590.9bNT$98.7bNT$10.1b17.1x58.7x6x
Sun, 04 Jun 2023NT$580.9bNT$97.8bNT$11.0b16.8x52.7x5.9x
Price to Earnings Ratio

52.7x


Total Market Cap: NT$580.9bTotal Earnings: NT$11.0bTotal Revenue: NT$97.8bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Pharma Industry Price to Earnings3Y Average 62.9x202420252026
Current Industry PE
  • Investors are pessimistic on the Taiwanese Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 31.3x which is lower than its 3-year average PE of 62.9x.
  • The 3-year average PS ratio of 5.9x is higher than the industry's current PS ratio of 4.8x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 20% per year over the last three years.
  • Revenues for these companies have grown 7.9% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Taiwanese Healthcare industry?

TW Market8.41%
Healthcare1.30%
Pharma-1.12%
Pharma-1.12%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
4743 Oneness BiotechNT$50.803.7%
+NT$862.6m		-14.5%PS173.2x
4127 Tien Liang BioTechNT$66.7028.3%
+NT$672.7m		83.7%PE481x
6634 Sinew PharmaNT$68.204.9%
+NT$228.1m		35.9%PS103444.8x
6586 CHO PharmaNT$66.601.1%
+NT$149.8m		65.5%PS9960.2x
1762 Chunghwa Chemical Synthesis & BiotechNT$39.702.5%
+NT$73.1m		35.5%PS3.1x

Latest News

4127
NT$66.70
Tien Liang BioTech
7D
28.3%
1Y
83.7%
6467
NT$122.00
Taho Pharmaceuticals
7D
-10.0%
1Y
121.4%
6919
NT$98.50
Caliway Biopharmaceuticals
7D
-2.5%
1Y
14.0%
6620
NT$72.90
Handa Pharmaceuticals
7D
-4.1%
1Y
-11.7%
1762
NT$39.70
Chunghwa Chemical Synthesis & Biotech
7D
2.5%
1Y
35.5%
6472
NT$346.50
Bora Pharmaceuticals
7D
-9.6%
1Y
-45.8%
4166
NT$23.55
Orient Pharma
7D
-6.2%
1Y
-25.5%
6576
NT$78.10
Foresee Pharmaceuticals
7D
-4.2%
1Y
21.1%
4123
NT$37.25
Center Laboratories
7D
-2.5%
1Y
-0.9%
7829
NT$41.40
Yoda Pharmaceuticals
7D
2.2%
1Y
n/a
4743
NT$50.80
Oneness Biotech
7D
3.7%
1Y
-14.5%
6535
NT$124.00
Lumosa Therapeutics
7D
-3.1%
1Y
-23.0%
4108
NT$12.25
PhytoHealth
7D
2.1%
1Y
-18.6%
6586
NT$66.60
CHO Pharma
7D
1.1%
1Y
65.5%
6634
NT$68.20
Sinew Pharma
7D
4.9%
1Y
35.9%
6709
NT$25.80
Advagene Biopharma
7D
2.8%
1Y
51.8%